Sign In
Buy ASPI
$7.55
-0.780 (-9.36%)
At Close: Jun 03, 2026
ASP Isotopes Inc. Announces Expected Commencement of Dual Listing on Johannesburg Stock Exchange
09:00am, Friday, 08'th Aug 2025
WASHINGTON, Aug. 08, 2025 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. NASDAQ: ASPI ("ASP Isotopes” or the “Company”), an advanced materials company dedicated to the development of technology and proce
- IsoBio, Inc. (IsoBio) is a U.S.-based radiotherapeutic development company focused on developing a broad pipeline of mAb-based radioisotope therapeutics, known as antibody-isotope conjugates (AICs
Competition Commission of South Africa Approves the Offer by ASP Isotopes Inc. for Renergen Limited
08:59am, Friday, 25'th Jul 2025
WASHINGTON, D.C., July 25, 2025 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. NASDAQ: ASPI ("ASP Isotopes” or the “Company”), an advanced materials company dedicated to the development of technology and
ASP Isotopes Inc. Announces Pricing of $60 Million Underwritten Registered Direct Offering of Common Stock
06:15pm, Wednesday, 23'rd Jul 2025
WASHINGTON, July 23, 2025 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. NASDAQ: ASPI ("ASP Isotopes” or the “Company”), today announced the pricing of an underwritten registered direct offering of 7,500
Shareholders of Renergen Limited Approve Proposed Acquisition by ASP Isotopes Inc.
08:00am, Friday, 11'th Jul 2025
WASHINGTON, July 11, 2025 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. NASDAQ: ASPI ("ASP Isotopes” or the “Company”), an advanced materials company dedicated to the development of technology and proce
Renergen's Phase 2 EPC Contractor Awarded Preferred Bidder Status
10:11am, Wednesday, 18'th Jun 2025
JOHANNESBURG, June 18, 2025 (GLOBE NEWSWIRE) -- Renergen is pleased to announce that preferred bidder status has been awarded to He4u consortium for the design, procurement, delivery, construction and
NEW YORK CITY, NY / ACCESS Newswire / June 12, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of ASP Isotopes Inc. ("ASP Isotopes" or "the Company"
WASHINGTON , June 11, 2025 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. NASDAQ: ASPI ("ASP Isotopes” or the “Company”), an advanced materials company dedicated to the development of technology and proc
Bronstein, Gewirtz & Grossman, LLC Encourages ASP Isotopes Inc. (ASPI) Shareholders to Inquire about Securities Investigation
10:00am, Tuesday, 10'th Jun 2025
NEW YORK CITY, NY / ACCESS Newswire / June 10, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of ASP Isotopes Inc. ("ASP Isotopes" or "the Company"
Bronstein, Gewirtz & Grossman, LLC Is Investigating ASP Isotopes Inc. (ASPI) And Encourages Shareholders to Connect
10:00am, Sunday, 08'th Jun 2025
NEW YORK CITY, NY / ACCESS Newswire / June 8, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of ASP Isotopes Inc. ("ASP Isotopes" or "the Company")
NEW YORK CITY, NY / ACCESS Newswire / June 5, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of ASP Isotopes Inc. ("ASP Isotopes" or "the Company")
ASP Isotopes Could Be The Next Big Nuclear Play
05:52am, Thursday, 05'th Jun 2025
AI-driven demand for reliable power is fueling a nuclear renaissance, with Google and tech giants investing heavily in next-gen reactor infrastructure. ASP Isotopes stands out for its isotope enrichme
Renergen's milestone deal shines spotlight on D3 Energy's South African gas potential
11:48pm, Wednesday, 04'th Jun 2025
In a significant move for the South African gas industry, Renergen Ltd (ASX:RLT, JSE:REN) on May 22 agreed to a merger with ASP Isotopes (NASDAQ:ASPI), positioning itself as a leading global supplier
ASP Isotopes Inc. to host Investor Access Event in South Africa from June 16-18, 2025
09:00am, Wednesday, 04'th Jun 2025
WASHINGTON, June 04, 2025 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. NASDAQ: ASPI ("ASP Isotopes” or the “Company”), an advanced materials company dedicated to the development of technology and proce
ASP Isotopes and Isotopia Announce Supply Agreement for Gadolinium-160 to Accelerate Terbium-161 Production for Advanced Cancer Therapies
08:30am, Wednesday, 04'th Jun 2025
- Gadolinium-160 is a critical precursor isotope for producing Terbium-161, an emerging medical isotope with significant potential in targeted radiotherapies.
